Clinical Trial Update: A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 multicenter trial is evaluating taurine as an adjunctive therapy for relapsing-remitting multiple sclerosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Taurine (taurine)

Snippet

Sponsor: Sichuan Academy of Medical Sciences | Conditions: Multiple Sclerosis (MS) Relapsing Remitting | Phase 2 | Status: NOT_YET_RECRUITING